Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07255300
What this trial is testing

Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Biomarkers of Aging

Who this might be right for
Fat MassRisk Factors Cardiovascular DiseaseEpigenetic Aging+4 more
Fondazione Valter Longo 135
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)Study completedNCT00964795
What this trial is testing

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Regeneron Pharmaceuticals 323
Not applicableStudy completedNCT04662944
What this trial is testing

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 494
Testing effectiveness (Phase 2)Ended earlyNCT03869684
What this trial is testing

Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Senju Pharmaceutical Co., Ltd. 13
Early research (Phase 1)UnknownNCT05005884
What this trial is testing

Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 80
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Not applicableUnknownNCT06268132
What this trial is testing

Longevity in Russia

Who this might be right for
LONGEVITY 1FrailtyAging+2 more
Center for Strategic Planning, of the Federal Medical and Biological Agency 4,000
Not applicableUnknownNCT01676506
What this trial is testing

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Russian Academy of Medical Sciences 300
Post-approval studies (Phase 4)Study completedNCT02060604
What this trial is testing

Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Università degli Studi di Brescia 60
Not applicableLooking for participantsNCT07515521
What this trial is testing

Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD

Who this might be right for
Age - Related Macular Degeneration (AMD)
Maximilian Pfau 150
Not applicableEnded earlyNCT00993330
What this trial is testing

Macular Pigment Optical Density in Healthy Subjects

Who this might be right for
Age Related Macular Degeneration
Medical University of Vienna 96
Post-approval studies (Phase 4)Study completedNCT03022292
What this trial is testing

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Who this might be right for
Wet Macular Degeneration
University of California, Los Angeles 26
Early research (Phase 1)Active Not RecruitingNCT06198413
What this trial is testing

LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Innostellar Biotherapeutics Co.,Ltd 12
Not applicableStudy completedNCT05602220
What this trial is testing

Heart Rate and Breathing Effects on Attention and Memory

Who this might be right for
AgingAlzheimer DiseaseAge-related Cognitive Decline
University of Southern California 91
Very early researchUnknownNCT02868424
What this trial is testing

Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation

Who this might be right for
Age Related Macular DegenerationMacular DegenerationAMD
The First Affiliated Hospital with Nanjing Medical University 6
Not applicableNot Yet RecruitingNCT07015255
What this trial is testing

Assessing the Burden of Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionAcute Lower Respiratory Tract InfectionsBronchiolitis+2 more
Abu Dhabi Health Services Company 1,500
Testing effectiveness (Phase 2)WithdrawnNCT02895815
What this trial is testing

Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

Who this might be right for
Visual AcuityGeographic AtrophyMacular Degeneration
Janssen Pharmaceutical K.K.
Testing effectiveness (Phase 2)Ended earlyNCT03656510
What this trial is testing

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 246
Not applicableStudy completedNCT00494325
What this trial is testing

The Role of Macular Pigment in Patients With Age-related Macular Degeneration

Who this might be right for
Age Related Maculopathy
Insel Gruppe AG, University Hospital Bern 480
Next Page